Drug giant Pfizer Inc. said it is planning to relocate the majority of its 530 employees at research facilities in Cambridge’s Alewife neighborhood to Kendall Square sometime next year, joining roughly 400 Pfizer employees who are already working in Kendall Square, a hotbed of the life sciences industry.
Pfizer said it plans to hire a broker to explore either selling or subleasing four buildings in Cambridge, including three on Cambridge Park Drive in Alewife.
Pfizer said one reason for the move is that it is looking to make the most efficient use of its global real estate. Another reason: Pfizer wants to create a single, integrated research-and-development community that can easily access and collaborate with biomedical researchers and other partners.
In Kendall Square, meanwhile, a building at 610 Main St. is under construction. Pfizer expects that building to be ready for occupancy early next year. Most employees from Alewife will move there. Other Alewife employees will relocate to an existing Pfizer space at 700 Main St., though others could be transferred to a complex in Andover, Pfizer said.
“We expect that there will be minimal impact to the size of Pfizer’s workforce in the state of Massachusetts, given that most colleagues will be moving to other Pfizer sites or leased space in Massachusetts,” a Pfizer spokeswoman said in an e-mail.
Chris Reidy can be reached at firstname.lastname@example.org.